Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Wednesday, 4 March 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSXV: $JWCA.V) (OTCQX: $JWCAF) (CSE: $TILT.C) (TSX: $FAF.TO) (CSE: $EASY.C)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSXV: $JWCA.V) (OTCQX: $JWCAF) (CSE: $TILT.C) (TSX: $FAF.TO) (CSE: $EASY.C)



Delta, Kelowna, BC, March 4, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public announcements.

But first, as more and more US States onboard some form of legal cannabis initiative in can difficult to keep track of which states are at which stages. Thankfully there is a new resource from TestClear.com which offers up to date information on the Where Marijuana is Legal in the U.S..

James E. Wagner Cultivation Corporation (TSXV: JWCA.V) (OTCQX: JWCAF) announced that it will be adding single origin lot kief and pre-rolls to its medical product shelf later today. This release marks the launch of JWC’s first cannabis 2.0 products into the Canadian market.

The kief and the pre-rolls are prepared using single origin lots of cannabis grown with JWC’s proprietary GrowthSTORM™ aeroponic cultivation platform. JWC is commencing its launch of these two product formats into the Canadian market later today via JWC’s online medical shop, which is accessible through its website www.jwc.ca.

Pre-Rolls: A single origin product, JWC cannabis pre-rolls are evenly milled, machine-rolled, and individually hand-finished in a convenient format.
Kief: A single origin extract product, these sugar-like crystals are known for their fulsome terpene profile, potency, and versatility. Carefully made using freshly harvested cannabis material, this product is recognized as one of the truest representations of the cannabis strain.

“Kief is a product we’re excited to introduce to Canadian cannabis consumers, as it’s our first extract product,” says Nathan Woodworth, President and CEO of JWC. “We prepare our kief on-site using single origin lots of freshly harvested cannabis material from one cultivar source. By using this preparation method, we can ensure the authenticity of the plant is respected, and the truest representation of the plant is fully present in our product. We’re not necessarily looking for an ultra-high THC content; we’re looking for an intensified concentrated aroma and a replicable experience.”

JWC is also focused on developing additional high-potency and versatile extract products including live resin and rosin to answer the diverse needs of Canadian medical patients and adult users. The Corporation believes these products will be in high demand as consumers become more educated and look for alternate ways to consume cannabis. The additional extract products are expected to launch later this spring, on both the medical and the adult-use recreational markets.

From cultivation and harvesting to packaging and processing, JWC’s extract products are produced on-site at its licensed facility, located at 855 Trillium Drive, in Kitchener, Ontario. Each of JWC’s cultivars are grown exclusively using the Corporation’s proprietary GrowthSTORM™ aeroponic technology, recognized for producing clean, consistent cannabis. JWC is on track to produce a total of over 35,000 kg of dried cannabis per year once its JWC2 cultivation facility is fully operational.

TILT Holdings Inc. (CSE: TILT) (OTCQB: TLLTF), a foundational technology cannabis platform comprised of assets to support brands worldwide, announced today that its subsidiary Jupiter Research, LLC is back online following Chinese New Year and minor delays associated with the novel coronavirus COVID-19.

“We are proud to report that manufacturing lines have been open since February 17, 2020, and can confirm our first post-Chinese New Year ocean and air shipments are en route,” stated Mark Scatterday, CEO of TILT and founder/CEO of Jupiter Research. “Each year, Jupiter strategically forecasts inventory positions for the Chinese New Year holiday and beyond, which aims to navigate our customers’ needs when production is halted for a variety of reasons. With product on hand stateside, our sales team has been actively receiving orders and fulfilling customer requests, along with our in-house print operations increasing capacity for domestic fulfillment.”

Jupiter’s warehouse located in Phoenix, Arizona, has inventory to help fulfill customer orders and is available for shipment with domestic carriers. Jupiter offers in-house printing at their headquarters facility in Phoenix to provide custom printed products.

“The Coronavirus outbreak in China has caused production delays across all industries, including ours, which produce products in Shenzhen and other manufacturing hubs along the China coast. Jupiter’s customer’s orders are being produced and shipped, which shows progress our manufacturers and Asian operations team have made. Our inventory position paired with our in-house print production has enabled our ability to continue placing P.O.’s, fulfill both custom and stock orders, and navigate the future potential for unforeseen delays in manufacturing,” added Mr. Scatterday.

As an ISO 9001 certified manufacturer, advanced protocols are in place including utilizing clean-room and gowning procedures in a controlled environment during the manufacturing process. Industrial ozone treatment is conducted nightly, and utilized in the storage areas of their facilities. All raw materials undergo a UV sterilization process prior to entering the production floor. Medical grade ethanol, known as an antiseptic for its bactericidal and antifungal effects, is currently used to clean the assembled components at several stages of the manufacturing process.

“Our ongoing commitment at Jupiter is to employee and customer safety, and the highest level of manufacturing processes,” Mr. Scatterday said. “We are optimistic for the future, and we appreciate our customers’ continued confidence and support.”

Fire & Flower Holdings Corp. (TSX: FAF) and its wholly-owned subsidiary Hifyre Inc., today announced the successful launch of the Spark Perks™ Fastlane™ "click-and-collect" service in Fire & Flower Ontario store locations in Ottawa and Kingston.

Click-and-collect online cannabis ordering and pickup services recently became permissible as a result of a change in the Ontario regulations earlier this year.
  
Fastlane is a key benefit of the Spark Perks members program that has been operating across Fire & Flower store locations in the provinces of Alberta, Saskatchewan, Manitoba and the Yukon territory. The Spark Perks program provides Fire & Flower customers with a one-to-one personalized customer experience that the Company sees as a key differentiator and value proposition for its customers.
  
The Spark Perks program has more than 73,000 members nationally who receive access to the Fastlane "click-and-collect" service, exclusive benefits and member-only events. On average, Spark Perks members spend 44% more though Fastlane, purchase more frequently and spend approximately 300% more per year than non-members of the program.

"Hifyre's ability to rapidly launch the Fastlane click-and-collect service in Ontario demonstrates our Company's core focus as a technology-enabled, retail 2.0 company," shared Trevor Fencott, Chief Executive Officer of Fire & Flower. "The Fastlane service will allow customers in Ontario to reserve products online for pickup in store, which is especially important when new, high-demand products come on to the market."

The Spark Perks Fastlane service will also be available to other retailers through Hifyre's strategic agreement with Cova Software Solutions Inc., announced on January 27, 2020.

SpeakEasy Cannabis Club Ltd. (CSE: EASY), a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act, announced that it has successfully completed its first harvest. 

SpeakEasy received its licence in November 2019 and immediately began preparations necessary to achieve harvest as quickly as possible. A large collection of unique genetic materials were brought on site prior to licensing and together with its craft style small batch techniques, all efforts were made to achieve the best finished product possible. That objective was achieved and the Company is thrilled with the result of all its efforts with this first of many harvests.

Founder, Marc Geen stated, "With the help and advice from our featured growers who each bring years of experience, we achieved our first harvest quickly, efficiently and with excellent results. I am amazed with the quality of this first harvest and so proud to be able to prove we can do what we have been promising our investors we can do."

A large amount of low-quality products are available in the legal market at the moment and remains unsold. There is high demand and standing orders for high quality products and SpeakEasy has received multiple offers for its first crop from all across the country.

Founder, Marc Geen further states, "We have been working with veteran and patient groups eager to become SpeakEasy clients, the quality and consistency just isn't there in the market to satisfy them. Our intent is to bring them the quality they need and have a consistent supply of the strains they desire."


SpeakEasy's plans include achieving its expanded sales licence and working directly with veterans,  seniors and advocacy groups that have thousands of patients looking for true high quality product available consistently and at a reasonable price. In addition, the retail distribution model in Ontario, Canada's largest provincial market, is changing and is expected to allow a more direct sales model between Licence Holder's and the retail stores. SpeakEasy believes that it will benefit from this new model due to its BC roots, authentic craft-style grow and high quality product.

Founder, Marc Geen states, "High quality cannabis will never go out of style and will not become a commodity. Although there is a glut of product on the market at the moment, it's a glut of low quality, greenhouse grown material that averages many months old. We have and will always produce the highest quality product grown in the traditional BC craft grow style that has achieved a reputation for world class cannabis."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800-665-0411

 





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


#CBD #Stock Exclusive: CBD Unlimited (OTC: $EDXC) Video Update with Stock News Report at the Nasdaq MarketSite, @CBDUnlimited_


#CBD #Stock Exclusive: CBD Unlimited (OTC: $EDXC) Video Update with Stock News Report at the Nasdaq MarketSite, @CBDUnlimited_

Stock News Report receives the latest on the Company's New Products, Expansion into International Markets, Mass Retail/Pharmacy Growth, Acquisition Targets, and Record Revenues.

CAVE CREEK, AZ, March 4, 2020 – (Investorideas.com newswire) – Breaking cannabis/CBD stock news - CBD Unlimited, Inc. (OTC: EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products is pleased to announce the Company’s interview with Stock News Report at the Nasdaq MarketSite is now publicly available for viewing.


On February 14, 2020, CBD Unlimited’s Chief Executive Officer and Chairman, Todd Davis, appeared live at the Nasdaq MarketSite with Stock News Now where Davis unveiled the Company’s successful product launch, growth within mass retail/pharmacy outlets, international growth, the company’s scientific background, testing product efficacy and dosing, acquisition targets, and record revenues. CBD Unlimited believes the Company is well positioned to capitalize on its large retail relationships while boosting sales in 2020.

The full interview may be found here: https://www.youtube.com/watch?v=IM-EK0wCX24

“It was a pleasure to join Jane King with Stock News Now. Our diligent work in the hemp marketplace is paying off with strong growth, revenues, and near-term completion of acquisitions that will truly position the company as an industry powerhouse,” commented Chief Executive Officer and Chairman, Todd Davis.

“All of CBD Unlimited’s products are designed with our scientifically-based therapeutics and formulated with natural adaptogen herbs such as ashwagandha, turmeric, ginger, and other viable plant properties that pair well with CBD,” continued Davis. “The synergies we have developed between mass retailers, mass pharmacy, and our dedicated partners will continue to help fuel the Company’s growth and we look forward to what the rest of 2020 has to hold for the hemp marketplace.”

About CBD Unlimited, Inc.
CBD Unlimited, Inc. develops and distributes all-natural CBD products derived from cannabis sativa plant (Hemp), containing less than 0.3% THC. Its products range from oils, capsules, topicals, and pet products, all with the shared purpose of therapeutic and pain relief for humans and pets. Phyto-Bites are CBD soft chews for animal use that are formulated to promote health and support the reduction of separation anxiety, pain, and inflammation. The science behind these products involves over half a decade of research and experiments in order to protect the accuracy in dosage and delivery of absorption per each serving.

In the interest of providing conformity with federal and state mandates, the company has incorporated the “Gorilla-Tek” platform into its business practices. The Gorilla-Tek platform is the first standardized hardware agnostic and software solution that tracks high-risk, high-shrink regulated, and restricted products maintained under federal/state/local compliance. The platform provides asset protection, inventory management, compliance and an “end of sale” technology integration. Based on principles developed by the pharmacological industry, the integrated “Gorilla-Tek” platform is tremendously efficient as it provides up-to-the-minute accounting and product details. Gorilla-Tek increases productivity, while reducing costs for retailers and costs in time for customers.

Website: www.cbdunlimited.com   

Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update any forward-looking statements.

Contact:
For further investor and media information, contact:
CBD Unlimited, Inc.
Todd Davis
Chairman & CEO
InvestorRelations@cbdunlimited.com
480-595-6900

Paid news Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure : this news release featuring CBD Unlimited, Inc. (OTC: EDXC), is a paid for news release on Investorideas.com  https://www.investorideas.com/News-Upload/
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp  Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

About Investorideas.com

Sign up for free stock news alerts at Investorideas.com

Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories



Tuesday, 3 March 2020

Investorideas.com - Cannabis Stock News: Beleave (CSE: BE) (OTC: BLEVF) Announces Approval for Sales in Alberta

Investorideas.com - Cannabis Stock News: Beleave (CSE: BE) (OTC: BLEVF) Announces Approval for Sales in Alberta

Investorideas.com - Cannabis Stock News Bites: Tilray, Inc. (Nasdaq: $TLRY) Reports Fourth Quarter And Full Fiscal Year 2019 Financial Results

Investorideas.com - Cannabis Stock News Bites: Tilray, Inc. (Nasdaq: $TLRY) Reports Fourth Quarter And Full Fiscal Year 2019 Financial Results

Investorideas.com - Cannabis Stock News: Beleave (CSE: BE) (OTC: BLEVF) Enters LOI with Dutchman's Gold to Partner on Cannabis Infused Honey Products

Investorideas.com - Cannabis Stock News: Beleave (CSE: BE) (OTC: BLEVF) Enters LOI with Dutchman's Gold to Partner on Cannabis Infused Honey Products

Investorideas.com - Top Chef's Joe Sasto Tours Family-Run Autumn Brands Farm, Talks "Farm-to-Table" Cannabis Cuisine

Investorideas.com - Top Chef's Joe Sasto Tours Family-Run Autumn Brands Farm, Talks "Farm-to-Table" Cannabis Cuisine

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSXV: $RLV.V) (OTCQB: $RLLVF) (OTC: $AGTK) (OTCQB: $NUGS) (OTCQB: $HLIX) (CSE: $SLNG.C) (OTC: $EDXC)



Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (TSXV: $RLV.V) (OTCQB: $RLLVF) (OTC: $AGTK) (OTCQB: $NUGS) (OTCQB: $HLIX) (CSE: $SLNG.C) (OTC: $EDXC)



Delta, Kelowna, BC, March 3rd, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Read this in full at


Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public announcements.

Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) announced that the Company’s subsidiary, BGX E-Health LLC, has shipped a total of CAD $130,000 worth of generic formulations to its customer, Innova Health Care based in Saudi Arabia.

This represents the first shipment of the initial CAD $1,000,000 purchase order the Company received, as mentioned in a press release dated October 30th 2019.

CEO of Relevium Mr. Useche stated “This first shipment to our international customer presents a new milestone for the Company as it embarks on expanding with global partners around the world for generic formulations and nutraceuticals.” Mr. Useche stated further “Our manufacturing partnerships have enabled us to expand our footprint into international markets such as Saudi Arabia and diversify our global sales channels which stem mainly through online sales”.

The Company anticipates that the shipment for the remainder of the purchase order, valued at approximately CAD $870,000 will be shipped towards the end of March 2020.

Agritek Holdings, Inc. (OTC: AGTK), a fully integrated, active real estate investor and white label provide for popular hemp brands, today announced that the Company will utilize its partnerships with licensed facilities in Florida, Colorado and California to focus on the cultivation and extraction of highly enriched CBG hemp, based on a new medical study that CBG material may have antibiotic potential to fight viral disease in humans.

Recently, McMaster University researchers have identified an antibacterial compound made by cannabis plants that may serve as a lead for new drug development. An interdisciplinary team of McMaster researchers found that the chemical compound, or cannabinoid, called cannabigerol (CBG) is not only antibacterial but also effective in mice against a resilient family of bacteria known as methicillin-resistant Staphylococcus aureus (MRSA). CBG achieved this by targeting the cell membrane of the bacteria. These findings in the laboratory were supported when mice with an MRSA infection were given CBG. The findings were published in the journal American Chemical Society Infectious Diseases.

Agritek Holdings presently has extracted multiple liters of hemp crude oil containing both CBD and CBG hemp material from last year’s farming operations and hemp harvest in Colorado to be used within multiple nutraceutical product lines.

“This new study clearly seems to show evidence and potential for use of CBG cannabinoids as antibiotics which have proven effective in mice against a resilient family of bacteria known as methicillin-resistant Staphylococcus aureus (MRSA). With rapid spread and growing worldwide concern of the coronavirus or COVID-19, perhaps further research on the effectiveness of cannabis’ deeper spectrum can be driven by new and exciting proofs that cannabis can one day help kill superbugs. This realistic approach might be a first important step in our need to improve society’s resistance to disease through a generic means,” stated B. Michael Friedman, CEO of Agritek holdings.

Despite the shock and awe of the traditional pharma community, it is no surprise to see powerful antibacterial effects from CBG in combination with other medications. The effect of the endocannabinoid system helps increase the potency of other antibacterial agents through its major functions. Beyond germs, cannabigerol can slow the spread of viruses throughout the body. CBG can stop the replication of viral infections by inhibiting calcium through several pathways, such as agonizing PPAR-y, a regulator of genetics, tumorigenesis, and many cellular processes. This leads to a widespread anti-inflammatory response that can help orchestrate white blood cells as they attack diseases, like pneumonia. In terms of relieving symptoms, nitric oxide is pneumonia’s weapon of inflammation which cannabis, CBD more than CBG, is an expert at disarming.

Research on this topic is still at an early stage to answer if cannabinoid formulations can truly deal with epidemics as severe as the current form of coronavirus now COVID-19 and originally the Wuhan Virus spreading in Southeast Asia, Europe and now entering the United States and Canada. We do not currently understand the pathogenesis of the disease, in order to develop vaccines or to employ medicinal intervention. Yet, that is the exact point of generic instant treatment, something that cannot be relied upon but can still be delivered with benefits that outweigh the risks. According to current research, CBG is non-intoxicating, mostly non-toxic, and non-sedating so it carries little known risk. The development of cannabinoid formulations might be able to unlock a range of interventions for many outbreaks, bacteria or viral.

Cannabis Strategic Ventures (OTCQB:NUGS), an emerging leader in the U.S. and California cannabis marketplaces, announced robust growth and significant financial improvements for the most recently completed financial period ending Dec. 31, 2019.  Revenue for the quarter ending Dec. 31 reached $1.35 million, representing sequential quarterly growth of approximately 91 percent, compared to the previous quarter.  Gross margins grew meaningfully while operating efficiencies improved significantly.

“We’re excited to see consistent revenue growth,” commented Simon Yu, CEO of the Company.  “In this highly regulated environment, it takes time to scale production.  With a considerable portion of the permitting and construction behind us, we are poised for continued growth in the California cannabis marketplace.”

In addition to top-line growth, the Company’s total assets as of the end of the December quarter 2019 was just over $18.7 million from only $2.8 million for the year-ago period.  Total current assets now equal approximately 113 percent of current liabilities.  Cash and accounts receivables more than doubled as of the end of the nine-month period.

Gross margins for the December 2019 quarter rose to just over 33 percent from 25 percent for the nine month period ending Dec. 31, 2019, and from no gross margin production for the year-ago quarter.   The net loss for the December quarter was cut to approximately $1.2 million from over $4.5 million during the September 2019 quarter.  Expense ratios improved markedly for the periods ending Dec. 31, 2019.

Mr. Yu continued, “Both the business operations and our financials continue to trend positively.  We have been able to substantially grow revenues and improve our gross margins while reducing our operational costs.  We feel we are now starting to hit our business stride in the California regulated marketplace, and we look forward to a fruitful 2020.”

This robust growth follows what was already strong growth during the September quarter of 2019.  For the nine month period ending December 31, Cannabis Strategic was able to increase revenues by more than $2 million.  The Company expects strong revenue growth to continue for the foreseeable future.

Helix Technologies, Inc. (OTCQB:HLIX), the leading provider of critical infrastructure services to the legal cannabis industry, announced today that it has extended two Government Traceability contracts in New York and North Dakota, and will deploy 2 advanced patient registries and upgraded traceability services in Arkansas and New Mexico.

New York and North Dakota have chosen to extend the contract of Biotrack’ss Government Traceability software.  Biotrack’s solution maintains a >99.99% uptime record, and best in class digital security features, such as being the only traceability system to deploy in the AWS FEDRAMP GOVCLOUD and to successfully complete a SOC 2 Type II Audit.
In addition, Arkansas and New Mexico also upgraded to the Biotrack advanced patient registry solution, including online application and approval, and mobile patient ID cards. 

These innovative solutions have reduced costs, approval time, and hassle for patients. Further, Biotrack is deploying upgrades to the New Mexico system that allows for on-site consumption, and reciprocity between states with medical cannabis programs, improving patient access.

“Delivering cutting edge systems requires fully-secure development capabilities and functionality coupled with the deployment expertise to meet the demands of the industry.  In the end, this is about patient access to medication,” said Helix Technologies CEO and Executive Chairman Zachary L. Venegas. “We consider it a tremendous responsibility to ensure patients have access to medication that is safe and tested, while also protecting the integrity of patient data privacy.”

SLANG Worldwide Inc. (CSE: SLNG), a leading global cannabis consumer packaged goods company with a robust portfolio of popular brands, today announced that it has entered into an acquisition agreement dated March 2, 2020 to acquire Cultivate Brands Corp.

Cultivate is a privately-owned company with a portfolio of brands and other intellectual property which are complementary to SLANG's portfolio. Its assets include extraction equipment and other machinery which SLANG intends to use within its network, cash of approximately CAD $4.5 million, and a strategic investment in a company within the supply chain. Cultivate is not currently consuming any cash in its operations.

The Acquisition is expected to further strengthen SLANG's position in Oregon, which the Company has identified as a core market for growth in 2020, due to its status as one of the most mature recreational markets in the United States. SLANG's O.penVAPE Craft RESERVE and Bakked Dabaratus products are strong performers in the state, and the Company recently announced a strategic partnership in Oregon with Cookies, a leading third-party brand that the Company expects to launch in Q2 2020.  The Oregon market had retail sales of $810M USD during 2019 and grew 27% year over year as of December 2019 (per BDS Analytics).

The Acquisition is structured as an all-stock transaction in which SLANG will issue a non-material amount of common shares in exchange for all the issued and outstanding shares of Cultivate.  The majority of the SLANG Shares issued pursuant to the Acquisition will be subject to a lock-up period with rolling expiration dates.

"We are pleased to execute a deal that contributes brands, IP, equipment, and capital to the already robust SLANG portfolio and balance sheet," said SLANG CEO Peter Miller. "The acquisition of Cultivate will provide a unique opportunity to generate value in several ways including new production assets, supply chain efficiencies and potential new products.  This acquisition is consistent with our disciplined growth strategy and our focus on capital efficiency."

"We are pleased to align with a leading cannabis CPG company like SLANG, with its proven capability to develop and grow brands," said Mihalis Belantis, Founder of Cultivate. "This transaction offers significant potential upside to our investors, as well as an opportunity to leverage and commercialize the foundational work we completed during the start-up phase of our business."

The Acquisition will be completed by way of three-cornered amalgamation and is anticipated to close in April 2020. Closing of the Acquisition is subject to the satisfaction or waiver of customary closing conditions, including the receipt of the approval of the shareholders of Cultivate and applicable regulatory approvals.

CBD Unlimited, Inc. (OTC: EDXC), formerly known as Endexx Corporation, a provider of innovative phytonutrient-based food and nutritional products, announced the Company's interview with Stock News Report at the Nasdaq MarketSite is now publicly available for viewing.                
On February 14, 2020, CBD Unlimited's Chief Executive Officer and Chairman, Todd Davis, appeared live at the Nasdaq MarketSite with Stock News Now where Davis unveiled the Company's successful product launch, growth within mass retail/pharmacy outlets, international growth, the company's scientific background, testing product efficacy and dosing, acquisition targets, and record revenues. CBD Unlimited believes the Company is well positioned to capitalize on its large retail relationships while boosting sales in 2020.        
The full interview may be found here: https://www.youtube.com/watch?v=IM-EK0wCX24   
"It was a pleasure to join Jane King with Stock News Now. Our diligent work in the hemp marketplace is paying off with strong growth, revenues, and near-term completion of acquisitions that will truly position the company as an industry powerhouse," commented Chief Executive Officer and Chairman, Todd Davis.                  
"All of CBD Unlimited's products are designed with our scientifically-based therapeutics and formulated with natural adaptogen herbs such as ashwagandha, turmeric, ginger, and other viable plant properties that pair well with CBD," continued Davis. "The synergies we have developed between mass retailers, mass pharmacy, and our dedicated partners will continue to help fuel the Company's growth and we look forward to what the rest of 2020 has to hold for the hemp marketplace."

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Cannabis Social Media
Download our Mobile App for iPhone and Android  

Contact Investorideas.com
800-665-0411

 



Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory


Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry September 13th - September 17th, 2021

Cannabis Deal Tracker: Investment and M&A Activity in the Cannabis Industry September 13th - September 17th, 2021